The Skin-Lightening Power of Tirbanibulin 1% Ointment
Abstract Background Tirbanibulin 1% ointment has been licensed to treat non-hyperkeratotic actinic keratosis (AK) on the face and scalp in adults. Recent evidence suggests that, besides the antineoplastic effect, tirbanibulin may also confer substantial cosmetic benefits to patients. Methods We repo...
Saved in:
Main Authors: | Federica Li Pomi, Andrea d’Aloja, Michelangelo Rottura, Mario Vaccaro, Francesco Borgia |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-11-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-024-01310-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prebiotic- and Panthenol-Containing Multipurpose Healing Dermocosmetics Post-Cryotherapy for Actinic Keratoses: Results of a Randomized Controlled Trial
by: Cesare Ariasi, et al.
Published: (2025-01-01) -
Pigmented pathological type and depth of follicular extension as predictors of treatment failure in 5-aminolevulinic acid photodynamic therapy for actinic keratosis: A retrospective, matched nested case-control study
by: Qinyuan Zhu, et al.
Published: (2025-04-01) -
From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments
by: Zhenlin Li, et al.
Published: (2025-01-01) -
Advances in the photodynamic treatment of solar keratosis
by: SHEN Haojia, et al.
Published: (2025-01-01) -
Comparative Efficacy and Tolerability of Imiquimod 3.75% Cream vs 5-Fluorouracil 4% cream in the Treatment of Actinic Keratosis: A Split-Face Study
by: Cesare Ariasi, et al.
Published: (2025-01-01)